Ad is loading...
BSX
Price
$91.50
Change
+$1.33 (+1.47%)
Updated
Nov 21 closing price
68 days until earnings call
ICLR
Price
$212.76
Change
+$9.09 (+4.46%)
Updated
Nov 21 closing price
89 days until earnings call
Ad is loading...

BSX vs ICLR

Header iconBSX vs ICLR Comparison
Open Charts BSX vs ICLRBanner chart's image
Boston Scientific
Price$91.50
Change+$1.33 (+1.47%)
Volume$4.2M
CapitalizationN/A
ICON
Price$212.76
Change+$9.09 (+4.46%)
Volume$2.43M
CapitalizationN/A
BSX vs ICLR Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BSX vs. ICLR commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongBuy and ICLR is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BSX: $91.50 vs. ICLR: $212.76)
Brand notoriety: BSX: Notable vs. ICLR: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 66% vs. ICLR: 182%
Market capitalization -- BSX: $100.1B vs. ICLR: $27.35B
BSX [@Medical Specialties] is valued at $100.1B. ICLR’s [@Medical Specialties] market capitalization is $27.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileICLR’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • ICLR’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 6 TA indicator(s) are bullish while ICLR’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 6 bullish, 3 bearish.
  • ICLR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BSX is a better buy in the short-term than ICLR.

Price Growth

BSX (@Medical Specialties) experienced а +4.46% price change this week, while ICLR (@Medical Specialties) price change was +6.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.47%. For the same industry, the average monthly price growth was -1.10%, and the average quarterly price growth was -2.69%.

Reported Earning Dates

BSX is expected to report earnings on Jan 29, 2025.

ICLR is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (+0.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than ICLR($27.4B). BSX has higher P/E ratio than ICLR: BSX (63.64) vs ICLR (44.81). BSX YTD gains are higher at: 58.277 vs. ICLR (-24.838). BSX has higher annual earnings (EBITDA): 3.45B vs. ICLR (1.52B). BSX has more cash in the bank: 865M vs. ICLR (380M). ICLR has less debt than BSX: ICLR (3.94B) vs BSX (9.49B). BSX has higher revenues than ICLR: BSX (14.2B) vs ICLR (8.12B).
BSXICLRBSX / ICLR
Capitalization100B27.4B365%
EBITDA3.45B1.52B227%
Gain YTD58.277-24.838-235%
P/E Ratio63.6444.81142%
Revenue14.2B8.12B175%
Total Cash865M380M228%
Total Debt9.49B3.94B241%
FUNDAMENTALS RATINGS
BSX vs ICLR: Fundamental Ratings
BSX
ICLR
OUTLOOK RATING
1..100
853
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
1062
SMR RATING
1..100
7276
PRICE GROWTH RATING
1..100
2091
P/E GROWTH RATING
1..100
5293
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (67) in the Pharmaceuticals Other industry is in the same range as BSX (81) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (10) in the Medical Specialties industry is somewhat better than the same rating for ICLR (62) in the Pharmaceuticals Other industry. This means that BSX’s stock grew somewhat faster than ICLR’s over the last 12 months.

BSX's SMR Rating (72) in the Medical Specialties industry is in the same range as ICLR (76) in the Pharmaceuticals Other industry. This means that BSX’s stock grew similarly to ICLR’s over the last 12 months.

BSX's Price Growth Rating (20) in the Medical Specialties industry is significantly better than the same rating for ICLR (91) in the Pharmaceuticals Other industry. This means that BSX’s stock grew significantly faster than ICLR’s over the last 12 months.

BSX's P/E Growth Rating (52) in the Medical Specialties industry is somewhat better than the same rating for ICLR (93) in the Pharmaceuticals Other industry. This means that BSX’s stock grew somewhat faster than ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXICLR
RSI
ODDS (%)
Bearish Trend 1 day ago
43%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
40%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 3 days ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
61%
Bullish Trend 1 day ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 5 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
57%
View a ticker or compare two or three
Ad is loading...
BSX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HAIN8.050.63
+8.49%
Hain Celestial Group
OVV46.590.85
+1.86%
Ovintiv
HITI2.670.01
+0.38%
High Tide
AIN82.53-1.03
-1.23%
Albany International Corp
GCTK0.25-0.02
-6.09%
GlucoTrack

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with SYK. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.47%
SYK - BSX
59%
Loosely correlated
+1.16%
RVTY - BSX
52%
Loosely correlated
-0.21%
ISRG - BSX
51%
Loosely correlated
+1.62%
EW - BSX
43%
Loosely correlated
+1.21%
ICLR - BSX
34%
Loosely correlated
+4.46%
More

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with IQV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+4.46%
IQV - ICLR
64%
Loosely correlated
+1.66%
RGEN - ICLR
62%
Loosely correlated
+2.06%
CRL - ICLR
44%
Loosely correlated
+3.35%
MEDP - ICLR
40%
Loosely correlated
+4.82%
TMO - ICLR
35%
Loosely correlated
+0.64%
More